Kaylie Metcalfe shares her experience of joining Mtech Access as a Consultant Health Economist in our Manchester office.
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
Visit our virtual booth We are delighted to announce that we will be exhibiting at The MedTech Forum on 30th May – 1st June in Dublin. The event is MedTech...
Read More
We answer audience questions from our NHS Whispers webinar on the economics of healthcare and the NHS
Araadhna Sinha (Associate health Economist) describes her experience of sharing her research with colleagues in the Mtech Access health economics journal club.
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider...
Read More
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
Araadhna Sinha tells us about her research evaluating NICE’s new disease severity modifier. Including the impact it could have had on past Health Technology Assessments.
Edyta Ryczek tells us about her research into the inclusion of Carer Health-Related Quality of Life measures in NICE Appraisals
